Cargando…

Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice

INTRODUCTION: Effects of antiepileptic drug (AED) load changes in patients with focal seizures have not been well evaluated. METHODS: SP1065 (NCT01673282) was a noninterventional, prospective, observational study conducted in a clinical practice setting. Patients (aged ≥18 years) with focal seizures...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinhardt, Fritjof, Weber, Yvonne G., Mayer, Thomas, Luef, Gerhard, Joeres, Lars, Tennigkeit, Frank, Dedeken, Peter, De Backer, Marc, Hellot, Scarlett, Lauterbach, Thomas, Webers, Tanja, Arnold, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698692/
https://www.ncbi.nlm.nih.gov/pubmed/31440722
http://dx.doi.org/10.1002/epi4.12346
_version_ 1783444595918503936
author Reinhardt, Fritjof
Weber, Yvonne G.
Mayer, Thomas
Luef, Gerhard
Joeres, Lars
Tennigkeit, Frank
Dedeken, Peter
De Backer, Marc
Hellot, Scarlett
Lauterbach, Thomas
Webers, Tanja
Arnold, Stephan
author_facet Reinhardt, Fritjof
Weber, Yvonne G.
Mayer, Thomas
Luef, Gerhard
Joeres, Lars
Tennigkeit, Frank
Dedeken, Peter
De Backer, Marc
Hellot, Scarlett
Lauterbach, Thomas
Webers, Tanja
Arnold, Stephan
author_sort Reinhardt, Fritjof
collection PubMed
description INTRODUCTION: Effects of antiepileptic drug (AED) load changes in patients with focal seizures have not been well evaluated. METHODS: SP1065 (NCT01673282) was a noninterventional, prospective, observational study conducted in a clinical practice setting. Patients (aged ≥18 years) with focal seizures were enrolled within 7 days of being prescribed adjunctive lacosamide. Observation period was ~6 months. Drug load was assessed using percentage change in ratio of actual prescribed dose and World Health Organization defined daily dose (DDD) for concomitant AEDs and all AEDs (including lacosamide). Subgroups were defined for patients with at least one concomitant sodium channel–blocking AED (SCB [+]) and those without (SCB [−]). RESULTS: A total of 311 patients were assessed for safety, 302 for measurement of drug load, and 240 for effectiveness. Ratio of AED dose to DDD decreased for concomitant AEDs (−9.6%) and increased for all AEDs (including lacosamide; 15.5%). Median reduction in focal seizure frequency per 28 days was 100% (range: −100, 2275.8). 70.4% and 61.7% of patients had a ≥50% or ≥75% reduction in seizure frequency, respectively; 50.8% became seizure‐free. In the SCB (+) subgroup (n = 149), ratio of AED dose to DDD decreased for concomitant AEDs (−15.0%) and increased for all AEDs (10.7%). In the SCB (−) subgroup (n = 153), ratio of AED dose to DDD decreased for concomitant AEDs (−4.4%) and increased for all AEDs (20.2%). Fifty‐seven patients (18.3%) reported ADRs, most commonly dose >400 mg/d (7.1%). Seventeen patients (5.5%) had ADRs leading to discontinuation. SIGNIFICANCE: Addition of lacosamide resulted in reduction of concomitant AED drug load regardless of whether concomitant AEDs were SCB (+) or SCB (−). These results indicate that addition of lacosamide in patients with focal seizures could allow clinicians to withdraw or reduce the dose of less well‐tolerated or less effective AEDs.
format Online
Article
Text
id pubmed-6698692
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66986922019-08-22 Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice Reinhardt, Fritjof Weber, Yvonne G. Mayer, Thomas Luef, Gerhard Joeres, Lars Tennigkeit, Frank Dedeken, Peter De Backer, Marc Hellot, Scarlett Lauterbach, Thomas Webers, Tanja Arnold, Stephan Epilepsia Open Full‐length Original Research INTRODUCTION: Effects of antiepileptic drug (AED) load changes in patients with focal seizures have not been well evaluated. METHODS: SP1065 (NCT01673282) was a noninterventional, prospective, observational study conducted in a clinical practice setting. Patients (aged ≥18 years) with focal seizures were enrolled within 7 days of being prescribed adjunctive lacosamide. Observation period was ~6 months. Drug load was assessed using percentage change in ratio of actual prescribed dose and World Health Organization defined daily dose (DDD) for concomitant AEDs and all AEDs (including lacosamide). Subgroups were defined for patients with at least one concomitant sodium channel–blocking AED (SCB [+]) and those without (SCB [−]). RESULTS: A total of 311 patients were assessed for safety, 302 for measurement of drug load, and 240 for effectiveness. Ratio of AED dose to DDD decreased for concomitant AEDs (−9.6%) and increased for all AEDs (including lacosamide; 15.5%). Median reduction in focal seizure frequency per 28 days was 100% (range: −100, 2275.8). 70.4% and 61.7% of patients had a ≥50% or ≥75% reduction in seizure frequency, respectively; 50.8% became seizure‐free. In the SCB (+) subgroup (n = 149), ratio of AED dose to DDD decreased for concomitant AEDs (−15.0%) and increased for all AEDs (10.7%). In the SCB (−) subgroup (n = 153), ratio of AED dose to DDD decreased for concomitant AEDs (−4.4%) and increased for all AEDs (20.2%). Fifty‐seven patients (18.3%) reported ADRs, most commonly dose >400 mg/d (7.1%). Seventeen patients (5.5%) had ADRs leading to discontinuation. SIGNIFICANCE: Addition of lacosamide resulted in reduction of concomitant AED drug load regardless of whether concomitant AEDs were SCB (+) or SCB (−). These results indicate that addition of lacosamide in patients with focal seizures could allow clinicians to withdraw or reduce the dose of less well‐tolerated or less effective AEDs. John Wiley and Sons Inc. 2019-06-22 /pmc/articles/PMC6698692/ /pubmed/31440722 http://dx.doi.org/10.1002/epi4.12346 Text en © 2019 UCB Pharma, S.A. Epilepsia Open published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Full‐length Original Research
Reinhardt, Fritjof
Weber, Yvonne G.
Mayer, Thomas
Luef, Gerhard
Joeres, Lars
Tennigkeit, Frank
Dedeken, Peter
De Backer, Marc
Hellot, Scarlett
Lauterbach, Thomas
Webers, Tanja
Arnold, Stephan
Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice
title Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice
title_full Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice
title_fullStr Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice
title_full_unstemmed Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice
title_short Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice
title_sort changes in drug load during lacosamide combination therapy: a noninterventional, observational study in german and austrian clinical practice
topic Full‐length Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698692/
https://www.ncbi.nlm.nih.gov/pubmed/31440722
http://dx.doi.org/10.1002/epi4.12346
work_keys_str_mv AT reinhardtfritjof changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice
AT weberyvonneg changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice
AT mayerthomas changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice
AT luefgerhard changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice
AT joereslars changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice
AT tennigkeitfrank changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice
AT dedekenpeter changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice
AT debackermarc changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice
AT hellotscarlett changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice
AT lauterbachthomas changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice
AT weberstanja changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice
AT arnoldstephan changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice